Business
Canadian Investors Are Missing the 52.6 Billion European Opportunity -- CFN Media
Canadian Investors Are Missing the 52.6 Billion European Opportunity -- CFN Media.
About this update from Wayland Group Corp
[{"type":"text","content":"\nSEATTLE, WA, Sept. 06, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Maricann Group Inc.’s (CSE: MARI) (CNSX: MARI) (MARI.CN) (OTCQB: MRRCF) growing footprint in Germany, Switzerland, Malta, and Italy making it one of the most promising opportunities in the space. With a modest C$268.5 million market capitalization, the market appears to have discounted its European operations that could both diversify and grow its revenue far beyond the Canadian market.\n The Canadian cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of recreational cannabis in October of this year. While many licensed producers are focused on meeting this domestic demand, investors are starting to realize that an even bigger opportunity is brewing in Europe—an emerging €52.6 billion opportunity with few established players. Growing European Market The European cannabis industry could reach €52.6 billion over the coming years, according to Prohibition Partners’ European Cannabis Report. With twice as many citizens as the U.S. and Canada combined, the firm believes that the region has the potential to become the largest single market over the next five years if most or all of its constituents legalize medical and/or recreational cannabis with programs similar to those in North America. Germany is the largest cannabis market in Europe with a medical and recreational market that could total €14.7 billion—or about 26 percent of the continent’s cannabis market. There are also ten other countries that have legalized medical marijuana and several others that could pass recreational laws over the next few years. These trends are quickly accelerating following Canada’s move to legalize recreational cannabis in October of this year. Canada has become a leading supplier to these new markets given its growing capacity and status as the world’s leading cannabis producer. Aurora Cannabis Inc. acquired CanniMed Therapeutics to target Denmark, Italy, and Germany; Aphria Inc. acquired Nuuvera Inc. to enter the Italian market; and, Marican...